Graves' Disease: Causes, Symptoms, and Treatment
This paper provides a structured overview of Graves' disease, an autoimmune disorder characterized by overproduction of thyroid hormones (hyperthyroidism). The paper identifies the disease, its signs, symptoms, and risk factors, then traces its etiology — specifically the role of IgG immunoglobulin and TSH receptor stimulation — and explains the pathogenesis involving B and T lymphocyte-mediated autoimmunity. Clinical manifestations affecting multiple organ systems are described, followed by a discussion of diagnostic criteria centered on the thyrotropin receptor antibody (TRAb) test. The paper concludes with evidence-based pharmacologic treatment options, including radioactive iodine and antithyroid medications, along with relevant nursing considerations.
- Introduction to Graves' Disease: Definition, symptoms, risk factors, and complications
- Etiology and Pathogenesis: Autoimmune mechanisms and lymphocyte-mediated thyroid dysfunction
- Clinical Manifestations: Multi-system physical and psychiatric symptoms described
- Diagnostic Criteria: TRAb test sensitivity and diagnostic accuracy
- Pharmacologic Treatment and Nursing Considerations: Radioactive iodine and antithyroid drug interventions
- References: Cited sources and bibliography
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Follows a clear, logical clinical structure — identification, etiology, pathogenesis, manifestations, diagnosis, and treatment — making complex medical content accessible.
- Integrates multiple peer-reviewed and clinical sources (Mayo Clinic, Bahn, Yeung, Rapoport) to support each section, lending credibility to each claim.
- Highlights a specific clinical sub-population (pregnant women) with historical context dating back to 1825, demonstrating depth beyond a basic disease overview.
Key academic technique demonstrated
The paper effectively uses disease framework organization — a standard technique in health sciences writing — by moving sequentially from identification through mechanism to treatment. Each section builds on the last, so the reader understands why certain symptoms occur before encountering diagnostic and treatment information.
Structure breakdown
The paper is divided into five substantive sections. The introduction identifies the disease, lists symptoms, risk factors, and complications including pregnancy-related risks. The second section covers etiology (IgG/TSH receptor dysfunction) and pathogenesis (lymphocyte-mediated autoimmunity). The third describes multi-system clinical manifestations. The fourth addresses TRAb-based diagnostic criteria. The fifth outlines pharmacologic interventions — radioactive iodine and antithyroid drugs — and nursing considerations. A Works Cited section follows APA-adjacent formatting.
Introduction to Graves' Disease
Graves' disease is a disorder of the immune system that results in the overproduction of thyroid hormones — a condition called hyperthyroidism. Because thyroid hormones affect many different body functions, the signs and symptoms linked to Graves' disease are wide-ranging and difficult to attribute to a single cause (Mayo Clinic). Although anyone can develop Graves' disease, it is far more common among women under the age of 40. In summary, Graves' disease is caused by a malfunction of the disease-fighting immune system, which leads to excessive production of thyroid hormones.
The Mayo Clinic identifies a number of signs and symptoms that may indicate Graves' disease, including: irritability or anxiety; a fine tremor in the hands or fingers; sensitivity to heat and increased perspiration; weight loss despite normal eating habits; an enlarged thyroid gland; disruption of normal menstrual cycles; erectile dysfunction or reduced libido; frequent bowel movements; bulging eyes; rapid heartbeat; and thick, red skin on the shins or tops of the feet.
Regarding the bulging eyes symptom, approximately 30% of those with Graves' disease experience this condition, known as Graves' ophthalmopathy. In this condition, the muscles and tissues surrounding the eyes swell and cause the eyes to bulge outward, accompanied by eye pain, puffy eyelids, double vision, loss of vision, and sensitivity to light (Mayo Clinic).
Risk factors for Graves' disease include: a family history of the disease; female sex (women are more likely to be affected); age under 40; the presence of other autoimmune conditions such as rheumatoid arthritis or type 1 diabetes; significant emotional or physical stress; pregnancy; and tobacco smoking (Mayo Clinic).
If left untreated, Graves' disease can lead to heart rhythm disorders and brittle bones. During pregnancy, it can cause miscarriage, fetal thyroid dysfunction, poor fetal growth, and even heart failure (Mayo Clinic). In rare but potentially life-threatening cases, the disease can progress to a condition known as "thyroid storm" (Mayo Clinic).
The relationship between Graves' disease and pregnancy has a documented history dating back to 1825, when a physician described a pregnancy ending in miscarriage due to thyrotoxicosis (Bahn, 2015). A 1929 study by Gardiner-Hill examined 26 cases of Graves' disease during pregnancy; of those, 12 were diagnosed during adolescence. Among the 14 women who developed the disease as adults, most presented during pregnancy or the postpartum period (Bahn, 168). These findings established that Graves' disease arising at times other than pregnancy or the postpartum period is relatively rare in women (Bahn, 168).
Create your account
Always verify citation format against your institution’s current style guide requirements.